A genetic analysis of HIV samples taken from about half the people infected in the largest HIV outbreak in Indiana history shows nearly all of them have the same strain of the virus, a finding one health expert says is a sobering reminder of how rapidly HIV can spread among intravenous drug users.
Indiana’s state epidemiologist, Pam Pontones, cautioned that the findings by the Centers for Disease Control and Prevention are “very preliminary.” But she said they suggest that the HIV strain detected in southeastern Indiana’s outbreak was introduced there during the past six to 12 months.
Sperm banking is a huge industry that has been around for decades but one that is relatively loosely regulated in the U.S.
Here are some things to know about the industry:
Few things are more frightening for a parent than racing to the hospital with a child who can’t breathe.
For many years, the LGBT community has experienced disparities in the health system as people have been denied the same rights as heterosexual Americans, have been found to have a high percentage of preexisting medical conditions and have experienced difficulty finding affordable health insurance. Now members of the LGBT community can have a sense of ease, as the Affordable Care Act and last summer’s Defense of Marriage Act ruling bring new health care rights and protections.
Under the ACA, insurance companies cannot discriminate based on gender identity or sexual orientation, meaning members of the LGBT community cannot be denied coverage or charged more for being lesbian, gay, bisexual or transgender.
For the first time, a large study suggests that a vitamin might modestly lower the risk of the most common types of skin cancer in people with a history of these relatively harmless yet troublesome growths.
In a study in Australia, people who took a specific type of vitamin B3 for a year had a 23 percent lower rate of new skin cancers compared to others who took dummy pills. In absolute terms, it meant that vitamin takers developed fewer than two of these cancers on average versus roughly 2.5 cancers for the others.
One of the hot new cancer immunotherapy drugs, Merck & Co.’s Keytruda, strongly benefited patients with melanoma, lung cancer and mesothelioma, according to three studies presented Sunday at the American Association for Cancer Research conference in Philadelphia.
One study, comparing Keytruda to Bristol-Myers Squibb Co.’s Yervoy, could give Merck a temporary advantage as the rivals battle for market supremacy and billions of dollars in annual sales from this new generation of drugs, which help the immune system destroy cancer cells. While research continues, the pace is quickening and big improvements in patient care regimens are likely fairly soon.
Leading neurologist David Perlmutter says our low-fat diet is causing brain disorders — but the damage can be reversed. When it comes to preserving our brain’s health and our mental faculties, we tend to think that it is not really up to us. It’s a matter of luck whether we become senile or not, because it is down to our genes.
All life cycles have watershed moments, times when another bridge has been irrevocably crossed. In the life of a child, that moment is often a joyful one. But for an elderly parent, life proceeds in reverse, leading often to sorrowful conclusions. My mother Liz, who is 93 years old, reached one of those watershed moments one night three years ago.
In their never-ending quest to maintain a youthful appearance, Americans of a certain age and mindset are increasingly choosing dermal fillers over surgery to smooth the cracks and crevices of time. Together with Botox, fillers can erase a decade or more of age’s cruelties in a relatively inexpensive and painless hour. Unlike cosmetic surgery, which carries the danger of branding you with that alien or “wind-tunnel” look, fillers are subtle and non-invasive.
Sitting down all day is bad for you, or so doctors say. There’s been a burst of interest in standing desks, but they’re not that easy to use, and it’s hard to motivate sitters to stand.
Stir, a company founded by a former Apple engineer, says it has the answer: a table that will nudge you to stand, with a gentle, one-inch rise and fall of its surface. If you take the suggestion, the table rises to standing height.